Joachim von Roy

Wool Equities Ltd. develops, manufactures and distributes wool products. It has retail and distribution access in the U.S. The company was founded on August 29, 1997 and is headquartered in Palmerston North, New Zealand.

Part of AgResearch Ltd., Orico Ltd. engages in the research and development of biotechnology and muscle growth therapeutics in livestock. The company is based in Dunedin, New Zealand.

Keraplast Manufacturing provides personal care products in nutritional and medical areas. It builds blocks at a cellular level, giving the human body structure and order and also develops healthy tissues, including skin, hair and nails. The company is headquartered in Lincoln, New Zealand.

Vital Food Processors Ltd. manufactures and produces kiwifruit based food products. Its brands include Kiwi Crush and Phloe Bowel Health. The company was founded by Michael Anthony Hollier and Bruce William Donaldson in 1991 and is headquartered in Auckland, New Zealand.

Part of Genesis Research & Development Corp. Ltd., BioStore NZ Ltd. operates a pharmaceutical company. The company is based in Auckland, New Zealand.

AgriGenesis Biosciences Ltd. focused on commercial physical and biological research. The company was headquartered in Auckland, new Zealand.

CuroNZ Ltd. is a clinical stage neurotherapeutics company based in Wellsford, New Zealand. The New Zealander company's vision is to transform the quality of life for severely neurologically affected children and adult patients. CuroNZ Ltd. focuses on developing a body and mind boosting drug therapy using a modified naturally occurring molecule called nrp2945. This molecule controls seizure activity and improves comorbidities in patients diagnosed with epileptic encephalopathy syndromes like Lennox-Gastaut syndrome and drug-resistant temporal lobe epilepsy. CuroNZ's peptide drug, nrp2945, has a minimal adverse event profile and is administered through subcutaneous injections every other day. The company has conducted successful phase I safety trials in healthy volunteers and a small phase II trial in patients with absence epilepsy.

Inventages Venture Capital Investment, Inc (Inventages Venture) is a venture capital firm founded in 2000 by Gunnar Carsten Weikert. The firm is headquartered in Nassau with an additional office in London.

Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA.